pazopanib has been researched along with Diabetes-Mellitus--Type-2* in 1 studies
1 other study(ies) available for pazopanib and Diabetes-Mellitus--Type-2
Article | Year |
---|---|
Improved glycemic control with the multi-receptor tyrosine kinase inhibitor pazopanib.
Topics: Aged; Antibiotics, Antineoplastic; Blood Glucose; Diabetes Mellitus, Type 2; Epirubicin; Humans; Hypoglycemic Agents; Indazoles; Male; Prostatic Neoplasms; Pyrimidines; Sulfonamides | 2010 |